ATG5 and cervical squamous cell carcinoma: ATG5 was identified as a risk prognostic predictor in CESC patients (HR 1.7; 95% CI, 1.0–2.8, p = 0.047), while another four ARGs were identified as favorable prognostic factors (HR < 1, p < 0.05).